Providing an Optimized and emPowered Pregnancy for You (PᵌOPPY) Feasibility Study
Study Details
Study Description
Brief Summary
The P3OPPY Project is one of five projects within the American Heart Association P3 EQUATE Network. The overarching goal of the P3 EQUATE American Heart Association Health Equity Research Network (HERN) is to promote equity in Maternal and Infant Health outcomes by identifying innovative and cost-effective strategies to enhance access to quality health information, care, and experiences during pregnancy, postnatal and postpartum/preconception periods, particularly for Black and under-served populations. Collectively, the investigators will collaborate with pregnant and postpartum individuals and their families, hospitals, and communities to discover ways to reduce racism and social problems that contribute to poor health outcomes.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
N/A |
Detailed Description
Feasibility Study Aims
-
To assess the feasibility of the digital health (DHI) and community health worker (CHW) interventions by assessing participant acceptance and use of the intervention.
-
To assess study enrollment to determine appropriateness and usefulness of the inclusion and exclusion criteria to estimate enrollment duration in the planned trial.
-
To determine the number of prenatal visits and the incidence of some of the maternal and neonatal outcomes (ones with higher prevalence) or surrogate outcomes that will be targeted in the planned factorial design randomized controlled trial. (Data will be collected on all relevant maternal and neonatal outcomes. The randomized feasibility design will allow for effect size estimates of the intervention on the incidence of maternal and neonatal outcomes, which will aid in determining the appropriate target outcomes as well as power calculation of the more definitive trial.)
The PᵌOPPY study is designed to support the American Heart Association's mission to improve maternal/infant health outcomes and address inequities in maternal/infant health care. The promise of digital health and community health worker engagement makes PᵌOPPY interventions potentially transformative, sustainable, and scalable for Non-Hispanic Black mothers and their infants from under-served communities in Alabama and beyond. The objective of this pilot study is to determine if it is feasible to randomize and implement digital health and community health worker interventions.
Design Summary
The investigators will challenge existing care paradigms by testing the effectiveness of integrating innovative platforms into the existing healthcare system, including existing digital health and community health worker programs from within the EQUATE consortium, to eliminate critical barriers to equitable healthcare access. After seeking input from a Community Advisory Board, these interventions will be refined and deployed for pilot testing. Individuals in Non-Hispanic Black communities at the highest risk of adverse pregnancy outcomes which were historically underrepresented in clinical research due to structural racism will be included. The investigative team employs experts across the community, maternal, and infant health continuum.
For this pilot, 40 eligible participants will be randomized, 10 to usual care, 10 to DHI, 10 to CHW, and 10 to DHI + CHW
Study Design
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| Experimental: Digital Health Intervention This group will receive routine prenatal care services. Additionally, those randomized to this arm will receive a DHI intervention. A modified DHI will be utilized that was developed by Memora Health in conjunction with EQUATE partners at UPenn and feedback from the POPPY Study Team and Community Advisory Board. All content is designed for 7th grade Flesch-Kincaid level or lower. |
Behavioral: Digital Health intervention
Health care information delivered via a link in a text message that is then opened in a secure browser.
Other Names:
|
| Experimental: Community health worker (CHW) Individuals randomized to this group will receive routine prenatal care services. Additionally, they will receive a CHW intervention. The CHW intervention will be adapted from an ongoing CHW program in Jefferson County, AL called "From Day One (FDO)", a comprehensive patient-centered program designed to educate and provide non-clinical, psychosocial, emotional support to expectant mothers from the 1st trimester of pregnancy through their child's first year of life. The intervention has been modified by the POPPY Study Team and Community Advisory Board. |
Behavioral: Community Health Worker
Health care information delivered via CHW.
Other Names:
|
| Experimental: DHI Plus CHW This group will receive routine prenatal care services. Additionally, this group will receive both DHI and CHW interventions. |
Behavioral: Digital Health Intervention plus Community Health Worker
Health care information delivered via DHI plus CHW
|
| No Intervention: Usual Care This group will receive routine prenatal care services. |
Outcome Measures
Primary Outcome Measures
- Participant acceptance of randomization arm / intervention [From randomization to 6 weeks postpartum]
Participant acceptance is defined as a yes response to this question: "I would recommend the care I received to someone in a similar situation."
- Participant use of digital health and/or community health worker interventions [From randomization to 6 weeks postpartum]
Use of the intervention for the digital health arm(s) is defined as the % of opened text messages. Use of the intervention for the community health worker arm(s) is defined as the % of planned sessions in which the participant engages with the community health worker.
Secondary Outcome Measures
- Outpatient Prenatal Care Visits [Duration of pregnancy through 6 weeks postpartum]
Number of outpatient prenatal care and postpartum visits
- Preterm Birth [At birth]
Delivery of a neonate at less than 37 weeks
- Neonatal birthweight [At birth]
Weight of neonate at birth
- Cesarean delivery [At birth]
Occurrence of a cesarean birth
- Maternal blood transfusion [Duration of pregnancy through 6 weeks postpartum]
Transfusion of blood products
- Breastfeeding intent [From randomization to delivery of the infant(s)]
Participant's self-reported intent of whether or not to express breast milk upon admission to the delivery-associated hospitalization
- Vaccination rate [Pregnancy through 6 weeks postpartum / 6 weeks of life]
The number of recommended vaccinations for which the mother and newborn accepted
- Maternal postpartum readmission [From discharge from the delivery-associated hospitalization to 6 weeks postpartum]
Admission of the mother to the hospital after discharge from the delivery-associated hospitalization
- Neonatal hospital readmission [Birth to 6 weeks of life]
Admission of a neonate to the hospital after discharge from the hospital after birth
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Self Identifies as Non-Hispanic Black
-
Between 16-49 years old
-
Pregnant individuals between 8⁰ - 22⁶ weeks gestational age
-
Live singleton or dichorionic twin gestation
-
Dating sonogram at <23 weeks gestation
-
Area Deprivation Index (ADI) National 4th or 5th Quintile
-
Planning to deliver at UAB Hospital
-
Speaks and writes in English
-
No indication for delivery at the time of enrollment
Exclusion Criteria:
-
Declines randomization
-
Speaks or writes in languages other than English
-
Currently incarcerated
-
Fetal demise diagnosed prior to enrollment
-
Known major structural chromosomal abnormalities prior to enrollment
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | University of Alabama at Birmingham | Birmingham | Alabama | United States | 35233 |
Sponsors and Collaborators
- University of Alabama at Birmingham
- American Heart Association
- ConnectionHealth
- Memora Health
Investigators
- Principal Investigator: Rachel Sinkey, MD, University of Alabama at Birmingham
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 300009897